SELECTBIO Conferences Extracellular Vesicle-based Therapeutics Summit
Extracellular Vesicle-based Dx & Rx Summit 2019
Date: March 28, 2019
Venue: Coronado Island Marriott Resort & Spa, Coronado, California, USA

Conference Chair

Lucia R. Languino

Lucia R. Languino
Professor of Cancer Biology, Thomas Jefferson University

Keynote Speakers

Dominique PV de Kleijn

Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands

Jan Lotvall

Jan Lotvall
Professor, University of Gothenburg; Founding President of ISEV

Hollis Cline

Hollis Cline
Chair of Neuroscience and Hahn Professor of Neuroscience, The Scripps Research Institute

Chulhee Choi

Chulhee Choi
Professor and Chair, BioMedical Imaging Center, Korea Advanced Institute of Science and Technology (KAIST), President, Cellex Life Sciences

Overview

SelectBIO Extracellular Vesicle-based Dx & Rx Summit 2019 focuses on the emerging field of engineering of exosomes and extracellular vesicles as a delivery tool for therapeutics moieties.

The ability to engineer EVs and the ability of EVs to target specific sites offers the ability to tailor therapeutics with exquisite targeting ability and opens up a whole new class of therapeutics which are classified as biologicals and which do not have the side effects and toxicity associated with small molecule-based therapies.

This summit explores this topic and takes a deep dive into the technology platforms, diseases targeted and clinical results-to-date.

This summit is co-located and concurrent with the Circulating Biomarkers World Congress 2019 and Liquid Biopsies 2019 and Flow Cytometry 2019: Biomarkers & Diagnostics events providing a 360o view of the field of exosomes and other circulating biomarker classes from biomarker/diagnostic potential to therapeutics opportunities in the future.

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 15 March 2019

Agenda Topics

  • Engineering EVs as Biologic Drugs
  • Engineering Exosomes and Extracellular Vesicles (EVs)
  • Ex Vivo Production of Large Quantities of EVs: Challenges and Opportunities
  • Stem Cell-based EVs for Regenerative Medicine

Sponsorship and Exhibition Opportunities

For more details, please contact us.

Confirmed Speakers to date

Randolph Corteling, Head of Research, ReNeuron
Clayton Deighan, Regional Sales Director, NanoView Biosciences
Daniel Gau, Head of Business Development, Unicyte AG
Michael Graner, Associate Professor, Dept of Neurosurgery, University of Colorado Anschutz School of Medicine
Dana Larocca, VP Discovery Research, AgeX Therapeutics
Aurelio Lorico, Professor of Pathology, Touro University Nevada
John Ludlow, Executive Director, Regenerative Medicine, Zen-Bio, Inc.
Shannon Pendergrast, Chief Scientific Officer, Ymir Genomics
Davide Trotti, Professor, Scientific Director, Weinberg ALS Center, Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson University


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks
Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean


Update History
2019/03/13
Agenda,Speaker,Sponsor updated
2019/01/29
Agenda,Speaker updated
2019/01/07
Sponsor updated